HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Epsilon aminocaproic acid for management of traumatic hyphema with large blood clot in the anterior chamber].

Abstract
Epsilon aminocaproic acid (EACA) is an antifibrinolytic agent currently used in the management of traumatic hyphema. It is effective in reducing the rebleed rate, but a long-standing blood clot in the anterior chamber predisposes to complications, such as corneal blood staining and elevated intraocular pressure. We assume that a large blood clot in the anterior chamber might be a contraindication to the use of EACA.
AuthorsR Kotas, D Neumann, I Ashkenazi
JournalHarefuah (Harefuah) Vol. 119 Issue 9 Pg. 269-70 (Nov 01 1990) ISSN: 0017-7768 [Print] Israel
PMID2258114 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Aminocaproic Acid
Topics
  • Adult
  • Aminocaproic Acid (therapeutic use)
  • Contraindications
  • Eye Injuries (complications)
  • Humans
  • Hyphema (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: